Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D&T) Committee Meeting Results for: March 16, 2016

Drugs and Therapeutics (D & T) Committee Meeting Results March 16, 2016
Drug Name	Review Type	Committee Recommendation	Prior Approval Status – Final Determination
Prezcobix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Envarsus XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Nucala	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Zepatier	New Drug Initial Review	Preferred with Prior Approval Required	Preferred with Prior Approval Required
Zomacton	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Veltassa	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Kitabis PAK	New Drug Appeal	Require Prior Approval	Prior Approval Required
Jadenu	New Drug Appeal	Require Prior Approval	Prior Approval Required
Triumeq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Invega Trinza	New Drug Appeal	Require Prior Approval	Prior Approval Required